2016 / Randomized, double-blind, placebo-controlled trial
Garlic powder supplementation significantly reduced body weight and body fat mass in patients with nonalcoholic fatty liver disease.
In this trial, 110 subjects with NAFLD were randomly assigned to receive either two garlic tablets daily (containing 400 mg of garlic powder) or placebo tablets. The intervention group demonstrated significant reductions in body weight and body fat mass (P < 0.05). Percentage change in body weight was significantly greater in the intervention group compared to the control group (-2.6 vs. -0.7, P = 0.02). Neither group showed significant changes in total body water or lean body mass (P > 0.05), and no serious side effects were reported.
Soleimani D, Paknahad Z, Askari G, et al. Adv Biomed Res, 2016. PMID 26955623